Volume 6.26 | Jun 20

Volume 6.26, June 20, 2005
     In this issue: Science | Policy | Business | NIH | CBER | Regulatory
Cell Therapy News on Facebook  Cell Therapy News on Twitter

Top Stories

Story: Researchers Create Way to Generate Brain Cells in Lab

Story: Arteries Bio-Engineered From Elderly Cells


Australia Scientists Make Blood From Human Stem Cells
Australian scientists say they have found a way to make blood cells in volume out of human master cells, which could eventually lead to production of safe blood cells for transfusions and organ transplants.

Stem Cells Found In Cerebellum; Possible Cell of Origin for Childhood Brain Tumors
Researchers at Duke University Medical Center have discovered the presence of stem cells in the cerebellum, a brain region where a deadly type of brain tumor originates. 

Most Common Lung Cancers May Begin in Newly Discovered Cells
The most common form of lung cancer may begin in a group of newly isolated lung stem cells, according to researchers from the Howard Hughes Medical Institute.

Transplantation of Spermatogonial Stem Cells Isolated from Leukemic Mice Restores Fertility without Inducing Leukemia
In a study appearing online on June 16 in advance of print publication in the July 1 issue of the Journal of Clinical Investigation, Akira Tsujimura and colleagues from Osaka University describe a way in which healthy germ cells, including spermatogonial stem cells, can be distinguished and completely separated from leukemic cells in mice, and then harvested and preserved.

Parkinson’s Jab Tests ‘Promising’
Scientists trying to find a way to beat Parkinson’s disease are reporting promising tests of a vaccine in mice.

Parents Believe Umbilical Cord Blood Injections Help Their Son with Cerebral Palsy, But Doctors Warn of Ethics Violations, Faulty Science
Since receiving the stem cell therapy, the Sussers said Adam has been able to do something a Miami doctor deemed impossible – see.

Humanized Antibody Offers Hope in Ulcerative Colitis
A humanized antibody that targets immune cells in the gut appears to offer relief for people with active ulcerative colitis.

Stem Cell Training Program to Make its Stanford Debut; Talks to Be Given by Noted Korean Researcher, British Scientist Who Cloned Sheep and Chair of California Stem Cell Institute
For the first time ever, an advanced training program that teaches how to create and maintain embryonic stem cell lines will be offered outside of the University of Pittsburgh, where it originated in 2003.

Embryonic Stem Cell Cures a Long Way Off, Experts Warn
A leading British medical journal has published an editorial warning against the “hype” surrounding recent advances in stem cell research.

Another Successful Implant: Opportunity Knocks for Major New Cell Therapy Research Centre
Recognised cellular expert doctor Eduardo Anitua is planning to build a pioneering training and research centre in Armentia to develop his discoveries.


Bystander Effect-mediated Gene Therapy of Gliomas Using Genetically Engineered Neural Stem Cells

Identification of Expandable Human Hepatic Progenitors which Differentiate into Mature Hepatic Cells in Vivo

Modulating Gene Expression in Stem Cells without Recombinant DNA and Permanent Genetic Modification

Myocardial Restoration with Embryonic Stem Cell Bioartificial Tissue Transplantation

Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts


German Chancellor Backs Stem-cell Research
Chancellor Gerhard Schroeder has publicly endorsed easing Germany’s restrictive law on stem-cell research, saying the country risks being left behind.



Advanced Cell Technology Expands Senior Scientific Team into California
Michael West, Ph.D., President and Chief Scientific Officer of A.C.T. Holdings, Inc. and its wholly-owned subsidiary, Advanced Cell Technology, Inc. (collectively, “ACT”) announced today the expansion of ACT’s senior scientific team with the addition of senior scientists that will add to the existing California team.

AmCyte to Announce Advances in Adult Stem Cell Regenerated Islet Program at the International Society for Stem Cell Research 3rd Annual Meeting
AmCyte Inc., a leader in encapsulated islet replacement and pancreatic adult stem cells, will present results from its Adult Stem Cell Regenerated Islet Program at the 3rd Annual Meeting of the International Society of Stem Cell Research, taking place in San Francisco, June 23-25, 2005.

CalbaTech LifeStem Files for Stem Cell Delivery Device Patent
CalbaTech, a life sciences company concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, announced that its wholly owned subsidiary, LifeStem, has filed a U.S. patent application for its Stem Cell Delivery Device.

ChondroGene Inc. Enters Into Clinical Collaborations With Two Malaysian Hospitals
ChondroGene Limited announced today that it has entered into clinical collaborations with Lam Wah EE Hospital and Island Hospital, two leading hospitals in Penang, Malaysia.

Immunomedics, Inc. Awarded U.S. And Australian Patents For Autoimmune Disease Therapy With CD22 Antibodies
Immunomedics, Inc. , a leading biopharmaceutical company focused on developing monoclonal antibodies, today announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

MultiCell Technologies and XenoTech LLC Jointly Announce Shrink Wrap Vial Sales Launch for Immortalized Hepatocytes
MultiCell Technologies, Inc. (OTCBB: MCET), a leading supplier of immortalized non-tumorgenic human hepatocytes as pharmaceutical candidate optimization tools, announced sales of the Fa2N-4 hepatocytes in shrink-wrapped vials.


Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer. 

“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:

Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1  Vol. 2
Cell Therapy Order Form

“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:

Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form

The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.

A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents

Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents



NIH Guide for Grants and Contracts – Week Of June 17, 2005


All new CBER information can be reached from the What’s New page

Medical Device Notification: Misys Laboratory Blood Bank and Blood Donor, Version 6.1 (Misys Healthcare System)

RAPS Advertising, Promotion & Labeling Conference (Slides)




Medical Devices; Medical Device Reporting; Confirmation of Effective Date

For Country-Specific & International Regulatory Resources, Including Regulatory Agencies Such As the FDA, EMEA, & More, Please Visit The Regulatory Page On The Cell Therapy News Website 


To View an Up-to-Date List of Cell Therapy-Related Meetings, Please Visit The Meetings Page  On The Cell Therapy News Website


To View a List of Cell Therapy-Related Journals, Please Visit The Journals Page On The Cell Therapy News Website


For information on posting an opportunity email: [email protected]

Acting President
San Diego, California (California Institute of Regenerative Medicine)

Assistant Supervisor (Human Cellular Therapy) 
Rochester, Minnesota (Mayo Clinic)

Cell Processing Medical Technologists 
Oldsmar, Florida (Cryo-Cell International Inc.)

Cell Therapy Scientist 
Philadelphia, Pennsylvania (RheoGene, Inc.)

Cell Therapy Specialist 
Hackensack, New Jersey (Progenitor Cell Therapy, LLC)

Cell Therapy Supervisor 
New York, New York (New York Blood Center)

Cell Therapy Technologist 
New York, New York (New York Blood Center)

Cellular Production Lead Technician
Seattle, Washington (Fred Hutchinson Cancer Research Center)

Clinical Laboratory Scientist
Los Angeles, California (Cedars-Sinai Medical Center)

Clinical Consultant  
Deerfield, Illinois (Baxter Healthcare)

Consultant– (AABB)

Director of Cell Therapy
New York, New York (New York Blood Center)

Director of Research Programs 
Toronto, Ontario (Ontario Genomics Institute)

Faculty Positions 
Singapore (John Hopkins Singapore)

Instrumentation Engineer II 
Gaithersburg, Maryland (Maxcyte)
Laboratory Manager 
Hackensack, New Jersey (Progenitor Cell Therapy, LLC)

Laboratory Supervisor (Stem Cell Lab)
Charlottesville, Virginia (University of Virginia Health System)

Manager, Device Engineering
Gaithersburg, Maryland (Maxcyte)

Manager, Quality Assurance 
Gaithersburg, Maryland (Maxcyte)

Marketing Assistant NEW!
Vancouver, British Columbia (StemCell Technologies)

Marketing Manager 
Denver, Colorado (Gambro BCT)

Medical Laboratory Technologist (Stem Cell)
Roswell Park Cancer Institute (Buffalo, New York)

Post Doctoral Fellowship 
Memphis, Tennessee (St. Jude Children’s Research Hospital)

Program Leader: Cell Biology (Professor/Associate Professor) 
Melbourne, Australia (Peter MacCallum Cancer Centre)

Quality Assurance Associate
Hackensack, New Jersey (Progenitor Cell Therapy, LLC)

Quality Control Coordinator NEW!
Vancouver, British Columbia (StemCell Technologies)

Quality Control Technologist NEW!
Vancouver, British Columbia (StemCell Technologies)

Quality Manager 
Sydney, Australia (Bone Marrow Transplant Network NSW)

Research Associate II 
Gaithersburg, Maryland (Maxcyte)

Scientific Director 
Boston, Massachusetts (CBR Insitute for Biomedical Research CHCT)
Scientific Review & Program Officers 
San Diego, California (California Institute of Regenerative Medicine)

Scientific Sales Representative NEW!
Vancouver, British Columbia (StemCell Technologies)

Scientific/Technical Officer,Stem Cell Transplant Laboratory/Haematology 
Sydney, Australia (SWAPS, Liverpool Hospital)

Scientist, Bacteriology
Potters Bar, Hertfordshire, England (National Institute for Biological Standards and Control)

Senior Hospital Scientist 
Sydney, Australia (Australian Stem Cell Facility Sydney Children’s Hospital)

Senior Officer for Medical & Ethical Standards 
San Diego, California (California Institute of Regenerative Medicine)

Senior Scientist 
Brussels, Belgium (Beta-Cell NV)

Stem Cell Lab Lead Technologist
Boston, Massachusetts (Beth Israel Deaconess Medical Center)

Stem Cell Specialist
Philadelphia, PennsylvaniaA (Children’s Hospital of Philadelphia)

Stem Cell Techonologist 
Salt Lake City, Utah (University of Utah Hospital and Clinics Stem Cell Laboratory)

Supervising Medical Laboratory Technologist (Quality Assurance)
Buffalo, New York (Roswell Park Cancer Institute)

Supervising Medical Laboratory Technologist (HLA, Stem Cell, Therapeutic Apheresis) 
Buffalo, New York (Roswell Park Cancer Institute)

Supervisor Cellular Activities 
New York, New York (Memorial Sloan-Kettering Cancer Center)

Therapy Scientist
(Therapeutic Aphaeresis and Cell Therapy)
Denver, Colorado (Gambro BCT)


International Society for Cellular Therapy

Upcoming Meetings & Conferences:

2005 Cell Therapy Audioconference Series

5th Annual Somatic Cell Therapy Symposium. Bethesda, Maryland
Sept. 15-18, 2005

Profiled Journal



Cytotherapy now incorporates “Cytokines, Cellular & Molecular Theory”

Join ISCT ($130) and receive the journal as a benefit of membership

Current Volume: Volume 7, Number 2 / May 2005

Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.

 Learn more about Cell Therapy News:  Archives  |  Events  |  Update Profile  |  Contact Us